Page 145 WHO - Guidelines on the pharmacological treatment of persisting pain in children with medical illness

WORLD HEALTH ORGANIZATION SECRETARIAT

Andrew L. Gray
Senior Lecturer Barbara Milani
University of KwaZulu-Natal Technical Officer, Access to Controlled Medicines
Department of Therapeutics and Medicines Department of Essential Medicines and
Management Pharmaceutical Policies
Durban, South Africa
(Temporary adviser: Technical chair) Lulu Muhe
Medical Officer
Nicola Magrini Department of Child and Adolescent Health
Director
NHS Centre for the Evaluation of the Effectiveness Willem Scholten
of Health Care (CeVEAS) Team Leader, Access to Controlled Medicines
Modena, Italy Department of Essential Medicines and
(Temporary adviser: Methodologist) Pharmaceutical Policies

A.7.2 other contributors

WHO Steering Group on Pain Treatment Guidelines
Akiiki Bitalabeho, Medical Officer, Department of HIV; Meena Cherian, Medical Officer, Department
of Essential Health Technologies; Nicolas Clark, Medical Officer, Department of Mental Health and
Substance Abuse; Tarun Dua, Medical Officer, Department of Mental Health and Substance Abuse;
Shaffiq Essajee, Medical Officer, Department of HIV; Barbara Milani, Technical Officer, Department
of Essential Medicines and Pharmaceutical Policies; Lulu Muhe, Medical Officer, Department of
Child and Adolescent Health; Willem Scholten, Team Leader, Department of Essential Medicines and
Pharmaceutical Policies (Chairperson); Cecilia Sepulveda, Senior Adviser, Department of Chronic
Diseases and Health Promotion.

WHO Expanded Review Panel
Gauhar Afshan (Pakistan), Hendrina Jacomina Albertyn (South Africa), Jane Ballantyne (USA), Rae
Frances Bell (Norway), Robert Bennett (USA), Mariela S. Bertolino (Argentina), Kin-Sang Chan (China),
David Christopher Currow (Australia), Henry Ddungu (Uganda), Liliana de Lima (Colombia/USA), Julia
Downing (United Kingdom/Uganda), Marie Therese Fallon (United Kingdom), Allen Finley (Canada),
Nanna Finnerup (Denmark), Kathleen Foley (USA), Ajunan Ganesh (USA), Huda Abu-Saad Huijer
(Lebanon), Mary Korula (India), Leora Kuttner (Canada), John Lee (United Kingdom), Elizabeth Molyneux
(Malawi), Bart Morlion (Belgium), Srinivasa Raja (USA), Rajat Ray (India), Carla Ripamonti (Italy), Ashok
Kumar Saxena (India), Neil Schechter (USA), Hardo Sorgatz (Germany), George Tharion (India), Monique
Maria Verduijn (the Netherlands), Chantal Wood (France), Boris Zernikow (Germany).

WHO Expert Advisory Panel on Drug Evaluation
Hoppu Kalle (Finland), Greg Kearns (USA), Marcus Reidenberg (USA).

WHO Guidelines Peer Review contributors
Dele Abegunde (WHO), Patricia Aguilar-Martinez (WHO), Jehan Al-Fannah (Oman), Michael Angastiniotis
(Cyprus), Maha Arnaout (Jordan), Lena L. Bergqvist (Sweden), Romesh Bhattacharji (India), Patricia
Bonilla (Venezuela), Hama Boureima-Sambo (WHO), Rosa Buitrago de Tello (Panama), Mei-Yoke Chan

> 142